Delivery Order SPE2DR25D2105-SPE2DR26F5VCU
- Not listed
- The Defense Logistics Agency awarded a $6,558.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on December 8, 2025, with completion targeted for December 9, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $37,029.83 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and is being fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $32,318.92 firm fixed price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 1, 2025, with an ultimate completion date of August 4, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $12,446.64 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on September 8, 2025, with completion scheduled for September 9, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office located in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $10,826.15 to AmerisourceBergen Drug Corp for RINVOQ ER 30 MG tablets (30-count units) on December 15, 2025, with completion expected by December 16, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $31.8K delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of June 3, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $13,485.90 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) on October 20, 2025, with completion targeted for October 21, 2025. This competitive award, issued under a firm fixed-price delivery order contract with no set-aside designation, represents a pharmaceutical supply delivery to be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The order is a child action under...
- The Defense Logistics Agency awarded a delivery order valued at $6,846.84 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) on December 17, 2025, with an ultimate completion date of December 18, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $35.7K to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on December 2, 2025, with an ultimate completion date of December 3, 2025. This firm fixed-price, non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle running through December 2026 that serves as a comprehensive pharmaceutical support...
- The Defense Logistics Agency awarded a delivery order valued at $8,496.41 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count unit dose packaging) on October 29, 2025, with completion required by October 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and identifies AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DR25D2105Indefinite Delivery Contract
- SPE2DR25D2105-SPE2DR26F5VCUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $32,896.76 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on December 17, 2025, with a completion date of December 18, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.9 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Logistics Agency's Medical Supply Chain. The company's extensive portfolio of federal contract awards demonstrates its capability to deliver a wide range of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This specific delivery order for RINVOQ ER reflects the company's ongoing role in supporting military and federal healthcare systems through the DLA's pharmaceutical prime vendor program structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.9k | 12/16/25 |